Commonwealth Equity Services’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $625K | Sell |
|
|||||
|
2025
Q2 | $525K | Sell |
|
|||||
|
2025
Q1 | $907K | Buy |
|
|||||
|
2024
Q4 | $636K | Sell |
|
|||||
|
2024
Q3 | $703K | Sell |
|
|||||
|
2024
Q2 | $771K | Sell |
|
|||||
|
2024
Q1 | $889K | Sell |
|
|||||
|
2023
Q4 | $712K | Sell |
|
|||||
|
2023
Q3 | $764K | Hold |
|
|||||
|
2023
Q2 | $708K | Sell |
|
|||||
|
2023
Q1 | $541 | Hold |
|
|||||
|
2022
Q4 | $548K | Buy |
|
|||||
|
2022
Q3 | $421K | Buy |
|
|||||
|
2022
Q2 | $366K | Buy |
|
|||||
|
2022
Q1 | $344K | Buy |
|
|||||
|
2021
Q4 | $528K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $283K | Sell |
|
|||||
|
2016
Q3 | $322K | Buy |
|
|||||
|
2016
Q2 | $255K | Buy |
|